FIELD: pharmacology.
SUBSTANCE: glycosylated polypeptide with a homogeneous structure of the sugar chain and having interferon-β activity is obtained synthetically.
EFFECT: sugar chain structure homogeneity and presence of sialic acid on the non-reducing end of the sugar chain increases the half-life of the glycosylated form of interferon in blood and improves its pharmacokinetic properties.
12 cl, 50 dwg, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
PROCESS FOR PREPARATION OF GLYCOPEPTIDE HAVING SIALYLATED SUGAR CHAIN, AND METHOD FOR PRODUCING SIALYL GLYCOASPARAGINE | 2012 |
|
RU2586524C2 |
POLYPEPTIDE GLYCOSYLATED WITH SIALYLATED SUGAR CHAIN | 2014 |
|
RU2668163C2 |
GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
LINEAR LIQUID PATHWAYS FOR WNT HEXAPEPTIDES | 2019 |
|
RU2801268C2 |
GLP-1 ANALOGUE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND THEREOF APPLICATION | 2010 |
|
RU2565536C2 |
LINEAR LIQUID PATHWAYS FOR WNT HEXAPEPTIDES | 2019 |
|
RU2799031C2 |
GROWTH HORMONE FACTOR PEPTIDE ANALOG AND METHOD AND COMPOSITION FOR STIMULATING GROWTH HORMONE SECRETION | 1991 |
|
RU2119800C1 |
METHOD FOR THERAPEUTIC PEPTIDES SYNTHESIS | 2012 |
|
RU2625793C2 |
Authors
Dates
2017-11-23—Published
2012-09-28—Filed